IGM Biosciences Inc.

NASDAQ: IGMS · Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 13, 2025, 3:59 PM
1.28
0.79%
After-hours: Aug 13, 2025, 06:49 PM EDT

IGM Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.68M 2.13M 1.07M n/a
Cost of Revenue
9.11M 8.28M 10.6M 7.72M
Gross Profit
-6.43M -6.15M -9.53M -7.72M
Operating Income
-208.58M -263.46M -227.96M -165.32M
Interest Income
12.79M 17.74M 7.04M 159K
Pretax Income
-195.79M -245.74M -221.1M -165.16M
Net Income
-195.79M -246.42M -214.25M -160.68M
Selling & General & Admin
50.41M 50.07M 49.74M 38.3M
Research & Development
160.85M 215.52M 179.29M 127.03M
Other Expenses
n/a n/a -181K 159K
Operating Expenses
211.26M 265.59M 229.03M 165.32M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
211.26M 265.59M 229.03M 165.32M
Income Tax Expense
n/a 678K n/a n/a
Shares Outstanding (Basic)
60.51M 52.31M 41.54M 33.48M
Shares Outstanding (Diluted)
60.51M 52.31M 41.54M 33.48M
EPS (Basic)
-3.24 -4.71 -5.16 -4.8
EPS (Diluted)
-3.24 -4.71 -5.16 -4.8
EBITDA
-199.47M -255.18M -221.88M -157.44M
EBIT
-208.58M -263.46M -227.96M -165.16M
Depreciation & Amortization
9.11M 8.28M 10.6M 7.72M